Bedrijfsoverzicht
Bio Green Med Solution, Inc. is a biotechnology enterprise that engages in the distribution, trading, and installation of protective and fire safety materials, equipment, and systems, alongside research and development activities for pharmaceuticals. The company operates within the Healthcare sector, specifically inside the Biotechnology industry, where it focuses on developing novel therapeutic solutions while maintaining a diversified business model that includes safety equipment distribution. As of the latest reporting period, the company's market capitalization stands at $5.57M, with annual revenue recorded at $747,000 over the trailing twelve months, while the employee count is listed as N/A. These financial figures indicate that the company functions as a micro-cap entity with limited scale, suggesting a position in the market where capital intensity is low but profitability remains a significant challenge for shareholders. The combination of pharmaceutical R&D and equipment distribution creates a unique operational profile that differentiates BGMS from typical pure-play biotechnology firms that rely exclusively on clinical trial milestones for revenue generation.
Financiële gezondheid
The financial performance of Bio Green Med Solution, Inc. over the trailing twelve months reflects a significant disparity between top-line activity and bottom-line profitability, with revenue at $747,000, net income at $-14,092,000, and EBITDA at $-8,422,000. The substantial gap between the modest revenue of $747,000 and the massive net loss of $14,092,000 reveals a highly leveraged cost structure where operating expenses, likely driven by R&D expenditures and distribution overheads, far exceed the company's ability to generate earnings. The free cash flow stands at $-10,077,875, indicating that the company is burning through its available liquidity to fund operations and research initiatives, which severely limits its immediate financial flexibility for capital expenditures or strategic acquisitions. Three distinct margin metrics paint a picture of operational inefficiency relative to sales: the gross margin is -90.1%, the operating margin is -162.5%, and the profit margin is 0.0%, showing that the company loses money on nearly every dollar of sales before interest and taxes. The balance sheet shows a cash position of $3.50M against negligible debt of $2,000, resulting in a debt-to-equity ratio of 0.03, which suggests a highly conservative capital structure with minimal leverage risk despite the current losses. Short-term liquidity appears robust with a current ratio of 4.70, indicating that the company possesses ample current assets to cover its short-term liabilities without immediate distress. However, the return on equity is -128.4% and the return on assets is -85.8%, metrics that reveal that management has not yet been able to generate positive returns on the capital invested by shareholders or the assets employed in the business.
Waarderingsbeoordeling
Valuation multiples for Bio Green Med Solution, Inc. are constrained by its lack of profitability, resulting in a P/E Ratio (TTM) and Forward P/E that are listed as N/A, which implies that traditional earnings-based valuation methods are currently inapplicable due to the negative earnings trajectory. The absence of a positive P/E suggests that the market does not value the company based on current earnings power but rather on asset value or future potential, which is reflected in the Price to Book ratio of 0.80. This ratio indicates that the stock is trading below its book value, suggesting that the market may be pricing in significant risks or expecting a turnaround in profitability before the share price can appreciate. Alternative valuation metrics such as the Price to Sales ratio of 7.45 and an EV/EBITDA of -0.24 further highlight the speculative nature of the investment, as the EV/EBITDA is negative, confirming that earnings before interest, taxes, depreciation, and amortization are not yet covering the enterprise value. The stock's price volatility is extreme, with a 52-week high of $100.80 and a 52-week low of $0.73, illustrating a massive range where the current trading price sits significantly below the recent highs. The Beta of -0.53 is a negative value, indicating that the stock price moves inversely to the broader market, adding a unique layer of volatility that does not align with standard market correlations.
Growth & Income
Growth metrics for Bio Green Med Solution, Inc. show that both Revenue Growth (YoY) and Earnings Growth (YoY) are listed as N/A, preventing a direct calculation of growth rates but signaling that the company is in an early or transitional stage of development where historical year-over-year comparisons may not be available or consistent. The company does not currently pay a dividend, as evidenced by a Dividend Yield of N/A and a Payout Ratio of 0.0%, meaning that the company retains all earnings—however negative—to fund its research and operational activities rather than distributing income to shareholders. Since the company is not a dividend payer, investors must rely on capital appreciation driven by future clinical successes or operational turnarounds rather than income generation from distributions. The overall growth and income profile is characterized by high risk and low immediate yield, with the company focusing entirely on reinvesting its remaining cash reserves to sustain R&D efforts and expand its distribution network in the healthcare and safety sectors.